What medications to give to an adult patient with hypoxic-ischemic encephalopathy (HIE) who continues to exhibit clonic jerks after receiving Levetiracetam (Keppra) 500mg?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Persistent Clonic Jerks in HIE After Levetiracetam 500mg

For an adult with hypoxic-ischemic encephalopathy experiencing ongoing clonic jerks after receiving only 500mg of levetiracetam, immediately administer a full loading dose of levetiracetam 30 mg/kg IV (approximately 2000-3000mg for an average adult) over 5 minutes, as the initial 500mg dose is grossly inadequate for seizure control. 1, 2

Why the Initial Dose Was Insufficient

  • The 500mg dose represents only 7-10 mg/kg for an average adult, which is one-third to one-quarter of the evidence-based loading dose required for seizure control 2, 3
  • The ESETT trial and ACEP guidelines establish that levetiracetam requires 30 mg/kg IV to achieve 68-73% efficacy in benzodiazepine-refractory seizures 1, 2
  • Lower doses (<20 mg/kg) demonstrate equivalent seizure termination rates to higher doses but this still requires at least 1400-1500mg for a 70kg patient, not 500mg 3

Immediate Treatment Algorithm

Step 1: Complete the Levetiracetam Loading Dose

  • Administer the remaining levetiracetam to reach 30 mg/kg total dose (subtract the 500mg already given) 2
  • Infuse over 5 minutes via IV 1, 2
  • No cardiac monitoring is required, as levetiracetam has minimal cardiovascular effects and 0% hypotension risk 1, 2

Step 2: If Seizures Persist After Full Levetiracetam Dose (60 minutes)

Add a second-line agent with a different mechanism of action:

Valproate 20-30 mg/kg IV over 5-20 minutes is the preferred choice because:

  • 88% efficacy with 0% hypotension risk 1, 2
  • Superior safety profile compared to fosphenytoin (which has 12% hypotension risk) 1, 2
  • Can be safely combined with levetiracetam without significant pharmacokinetic interactions 2

Alternative: Fosphenytoin 20 mg PE/kg IV at maximum rate of 50 mg/min if valproate is contraindicated:

  • 84% efficacy but requires continuous ECG and blood pressure monitoring 1, 2
  • 12% risk of life-threatening hypotension 1

Step 3: If Refractory to Both Agents (Refractory Status Epilepticus)

Initiate continuous EEG monitoring and escalate to anesthetic agents 2:

Midazolam infusion (first choice for refractory SE):

  • Loading dose: 0.15-0.20 mg/kg IV 2
  • Continuous infusion: 1 mg/kg/min, titrate up by 1 mg/kg/min every 15 minutes to maximum 5 mg/kg/min 2
  • 80% efficacy with 30% hypotension risk 2
  • Requires mechanical ventilation 2

Propofol (alternative):

  • 2 mg/kg bolus, then 3-7 mg/kg/hour infusion 2
  • 73% efficacy with 42% hypotension risk 2
  • Shorter ventilation time (4 days vs 14 days with barbiturates) 2

Pentobarbital (most effective but highest risk):

  • 13 mg/kg bolus, then 2-3 mg/kg/hour infusion 2
  • 92% efficacy but 77% hypotension risk requiring vasopressors 2

Critical Pitfalls to Avoid

  • Never use neuromuscular blockers alone (e.g., rocuronium) as they only mask motor manifestations while allowing continued electrical seizure activity and brain injury 2
  • Do not skip directly to third-line anesthetic agents until adequate doses of benzodiazepines and at least one second-line agent have been tried 2
  • Ensure benzodiazepines were given first - if not already administered, give lorazepam 4 mg IV at 2 mg/min immediately, as benzodiazepines are Level A first-line treatment 1, 2

Simultaneous Critical Actions

  • Check fingerstick glucose immediately and correct hypoglycemia 2
  • Search for reversible causes: hyponatremia, hypoxia, drug toxicity, CNS infection, stroke, intracerebral hemorrhage 1, 2
  • Maintain continuous oxygen saturation monitoring with supplemental oxygen available 2
  • Have airway equipment immediately available, as respiratory depression can occur with escalating therapy 2

Special Considerations for HIE Population

  • In post-cardiac arrest HIE patients, myoclonic status epilepticus may indicate Lance-Adams syndrome, which paradoxically may be compatible with good neurological outcome and should not be treated overly aggressively 2
  • However, ongoing clonic jerks require treatment to prevent secondary brain injury from continued seizure activity 1
  • Continuous EEG monitoring is essential to distinguish true epileptic activity from non-epileptic myoclonus 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Status Epilepticus Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

Is it safe to administer 3000mg of levetiracetam (Keppra) diluted in 100ml of Normal Saline (NS) over 30 minutes to an adult patient with a seizure disorder and normal renal function?
What is the recommended treatment for seizures with changing EEG (electroencephalogram) activity?
What to add to Levetiracetam 500 mg Q12 for ongoing seizures?
Is 30mg/kg of levetiracetam (Keppra) sufficient for treating status epilepticus, given that many sources recommend 60mg/kg?
What is the recommended dose of levetiracetam (Keppra) for a patient in status epilepticus?
Is an L5-S1 Transforaminal Lumbar Interbody Fusion (TLIF) procedure medically indicated for a male patient with severe back pain, weakness, and bilateral lower extremity pain, significant functional limitation, and a history of conservative management including physical therapy, pain management, and cortisone injections, with Magnetic Resonance Imaging (MRI) findings showing rectification of physiological lumbar curvature, global and diffuse bulging associated with neuroforaminal stenosis, and clear signs of radicular compression?
What is the recommended dose of dapagliflozin (SGLT2 inhibitor) for a patient with type 2 diabetes and impaired renal function (eGFR 56 ml/min)?
What is the typical timeframe for developing Human Papillomavirus (HPV) side effects after initial infection?
What is the management approach for unstable supraventricular tachycardia (SVT) in pediatric patients?
What does a Blood Urea Nitrogen (BUN)/creatinine ratio of 27 indicate in an adult patient and how should it be managed?
What is the recommended initiation protocol for Suboxone (buprenorphine) in a patient with a history of opioid use disorder who has not used opioids for 6 months?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.